Alpha-glutathione transferases in HCV-related chronic hepatitis: A new predictive index of response to interferon therapy?

Journal of Hepatology

Volumn 28, Issue 3, 1998, Pages 390-395

  Loguercio, Carmela ^a   Caporaso, Nicola ^a   Tuccillo, Concetta ^a   Morisco, Filomena ^a   Del Vecchio Blanco, Giovanna ^a   Del Vecchio Blanco, Camillo ^a  

^a NONE

Author keywords

Alpha glutathione transferases; Hepatitis C; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RELAPSE; VIREMIA;

EID: 0032032535     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80311-5     Document Type: Article

References (51)

1. Conjeevaram HS, Everhart J, Hoofnagle JH. Predictors of a sustained beneficial response to interferon alpha therapy in chronic hepatitis C. Hepatology. 22:1995;1326-1329.
2. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol. 22:1995;449-456.
3. Boya P, Larrea E, Alberdi A, Castelruiz Y, Beloqui O, Civeira MP, et al. Nuclear factor kappa B activity and oxidative stress in chronic hepatitis C (Poster). J Hepatol. 25:1996;84/31. (suppl 1).
4. Mena P, Ortiz A, Hernandez R, Cordero R. Hepatic lipoperoxidation and antioxidant enzymes in viral hepatitis. Hepatology. 19:1994;101.
5. Scheuer PJ, Ashrafzadeh P, Scherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology. 15:1991;567-571.
6. Gerber MA. Pathobiologic effects of hepatitis C. J Hepatol. 22:1995;83-86. (suppl).
7. Ademoglu E, Mutlu-Türkoglu U, Türkoglu S, Badur S, Uysal M, Toker G. The effects of interferon-α on serum lipid peroxidation and thiol status in chronic hepatitis C. VIII Biennial Meeting. 1-5 Oct. 1996;207 International Society for Free Radical Research, Barcelona. Abstracts.
8. Suarez M, Beloqui O, Ferrer JV, Gil B, Qian C, Garcia N, et al. Glutathione depletion in chronic hepatitis C. Int Hepatol Commun. 1:1993;215-221.
9. Meister A. On the biochemistry of glutathione. Taniguchi N, Higashi T, Sakamoto Y, Meister A. Glutathione Centennial. Molecular Perspectives and Clinical Implications. 1989;3-21 Academic Press Inc. San Diego.
10. Pompella A, Paolicchi A, Tongiani R, Tonarelli P, Comporti M. Pro-oxidant effects of γ-glutamyl transpeptidase activity: a novel mechanism of oxidant stress. VIII Biennial Meeting. 1-5 Oct. 1996;189 International Society for Free Radical Research, Barcelona. Abstracts.
11. Camps J, Crisóstomo S, García-Granero M, Riezu-Boj JI, Civeira MP, Prieto J. Prediction of the response of chronic hepatitis C to interferon-alfa: a statistical analysis of pretreatment variables. Gut. 34:1993;1714-1717.
12. Zein NN, Rakela J. Interferon therapy in hepatitis C. Semin Gastrointest Dis. 6:1995;46-53.
13. Sies H. Glutathione Conjugation Mechanisms and Biological Significance. 1988;Academic Press, London.
14. Lieberman MW, Barrios R, Carter BZ, Habib GM, Lebovitz RM, Rajagopalan S, et al. γ-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions? [review]. Am J Pathol. 147:1995;1175-1185.
15. Hayes PC, Bouchier IAD, Beckett GJ. Glutathione S-transferase in humans in health and disease. Gut. 32:1990;813-818.
16. Addya S, Mullick J, Fang Ji K, Avadhani NG. Purification and characterization of a hepatic mitochondrial glutathione-S-transferase exhibiting immunochemical relationship to the alpha-class of cytosolic isoenzymes. Arch Biochem Biophys. 310:1994;82-88.
17. Trull AK, Facey SP, Rees GW, Wight DGW, Noble-Jamieson G, Joughin C, et al. Serum α-glutathione-S-transferase: a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. Transplantation. 58:1994;1345-1351.
18. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
19. Thorburn D, Bird GLA, Spence E, MacSween RNM, Mills PR. α-Glutathione-S-transferase levels in chronic hepatitis C infection and the effect of α-interferon therapy. Clin Chim Acta. 253:1996;171-180.
20. Nelson DR, Lim HL, Oliver D, Qian KP, Davis GL, Lau JYN. α-Glutathione-S-transferase as a marker of hepatocellular damage in chronic hepatitis C virus infection. Am J Clin Pathol. 104:1995;193-198.
21. Bekett GJ, Hayles JD. Glutathoine-S-transferases: biomedical applications. Adv Clin Chem. 30:1993;281-380.
22. Detmer J, Lagier R, Flynn J, Zayati C, Kolberg J, Collins M, et al. Accurate quantification of HCV-RNA from all HCV genotypes using branched DNA (b-DNA) technology. J Clin Microbiol. 34:1996;901-907.
23. Loguercio C, Morisco F, Valenza CM, Guerriero C, Tuccillo C, Marino C. Plasma values of alpha-glutathione-transferases in healthy HCV-RNA positive subjects. Ital J Gastroenterol. 5:1994;98. (suppl 2).
24. Steegers EAP, Mulder TPJ, Bisseling JGA, Delemarre FMC, Peters WHM. Glutathione S-transferase alpha as marker for hepatocellular damage in pre-eclampsia and hellp syndrome [letter]. Lancet. 345:1995;1571-1572.
25. Boyer TD. The glutathione-S-transferases: an update. Hepatology. 9:1989;486-496.
26. Mannervik B. The isoenzymes of glutathione transferase [review]. Adv Enzymol. 157:1985;357-417.
27. Habig HW. Glutathione S-transferase: versatile enzymes of detoxication. Nygaard OF, Simic MG. Radioprotectors and Anticarcinogens. 1983;169-190 Academic Press, New York.
28. Aniya Y, Anders MW. Activation of rat liver microsomal glutathione S-transferase by reduced oxygen species. J Biol Chem. 264:1989;1998-2002.
29. Aniya Y, Naito A. Oxidative stress-induced activation of microsomal glutathione S-transferase in isolated rat liver. Biochem Pharmacol. 45:1993;37-42.
30. Adams DJ, Balkwill FR, Griffin DB, Hayes JD, Lewis AD, Wolf CR. Induction and suppression of glutathione transferases by interferon in the mouse. J Biol Chem. 262:1987;4888-4892.
31. Khan MF, Srivastava SK, Singhal SS, Chaubey M, Awasthi S, Petersen DR, et al. Iron-induced lipid peroxidation in rat is accompanied by preferential induction of glutathione S-transferase 8-8 isozyme. Toxicol Appl Pharmacol. 131:1995;63-72.
32. Beloqui O, Prieto J, Suàrez M, Gil B, Quian CH, Garcia N, et al. N-acetyl-cysteine enhances the response to interferon-α in chronic hepatitis C: a pilot study. J Interferon Res. 13:1993;279-282.
33. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res. 54:1994;3171-3172.
34. Kikayama M, Kobayashi Y, Kawasaki T, Yoshimi T. Hepatic lipid peroxidation in chronic hepatitis C [abstract]. Hepatology. 678:1995;276.
35. Chen G, Wang SH, Converse CA. Glutathione increases interleukin-2 production in human lymphocytes. Int J Immunopharmacol. 16:1994;755-760.
36. Ramadori G, Zum Büschenfelde KHM. Liver cells and cytokines. Curr Opinion Gastronterol. 9:1993;359-366.
37. Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Zum Büschenfelde KHM. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver. 14:1994;161-166.
38. Zum Büschenfelde KHM, Lohse AW, Gerken G, Treichel U, Löhr HF, Mohr H, et al. The role of autoimmunity in hepatitis C infection. J Hepatol. 2:1995;93-96.
39. Mondelli MU, Cividini A, Cerino A. Role of humoral immune response in hepatitis B and C virus infections. Eur J Clin Invest. 25:1995;543-547.
40. Peters M. actions of cytokines on the immune response and viral interactions: overview [special article]. Hepatology. 23:1996;909-916.
41. Hayes JD, Wolf CR. Role of glutathione-transferases in drug-resistance. Sies H, Ketherer B. Glutathione Conjugation. 1988;315-355 Academic Press, London.
42. Balart LA, Perrillo R, Roddenberry J, Regenstein F, Shim KS, Shieh YSC, et al. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon-alfa treatment. Gastroenterology. 104:1993;1472-1477.
43. Matsunaga T, Kojima J, Inoue A, Arao M. Prediction of sustained response to interferon alpha therapy with serum soluble interleukin 2 receptor levels in patients with chronic hepatitis C. Int Hepatol Comm. 3:1995;173-177.
44. Artini M, Natoli C, Tinari N, Costanzo A, Marinelli R, Balsano C, et al. Elevated serum levels of 90K/MAC-2BP predict unresponsiveness to α-interferon therapy in chronic HCV hepatitis patients. J Hepatol. 25:1996;212-217.
45. Horsmans Y, Brenard R, Geubel AP. Short report: interferon-α decreases C aminopyrine breath test values in patients with chronic hepatitis C. Aliment Pharmacol Ther. 8:1994;353-355.
46. Coverdale S, Byth K, Field J, Liddle C, Lin R, Farrell GC. Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology. 22:1995;1065-1071.
47. Tygstgrup N. Assessment of liver function: principles and practice [review article]. J Gastroenterol Hepatol. 5:1990;468-482.
48. Harrison DJ, May L, Hayes PC, Haque MM, Hayes JD. Glutathione S-transferases in alcoholic liver disease. Gut. 31:1990;909-912.
49. Mihim S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology. 25:1997;735-739.
50. Zenzen S, Lee IH, Roth WK. Mutations in the non-structural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology. 25:1997;740-744.
51. Venkatraman JT, Chandrasekar B, Dai Kim J, Fernandes G. Genotype affects the antioxidant enzymes activity and mRNA expression in liver and kidney tissue of autoimmune-prone MRL/MpJ-lpr mice. Biochem Biophys Acta. 1213:1994;167-175.